Clinical Trial Update: RCT Comparing Standard Cannula Delivered FS, UGFS and ClariVein® in the Management of SVI [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing standard cannula-delivered FS, UGFS, and ClariVein for superficial venous insufficiency and varicose veins was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Superficial Venous Insufficiency
• Varicose Veins

Drugs mentioned

• ClariVein (not specified)
• FS
• UGFS (not specified)

Snippet

Sponsor: Hull University Teaching Hospitals NHS Trust | Conditions: Superficial Venous Insufficiency, Varicose Veins | Phase 4 | Status: WITHDRAWN